MK0759

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0759, covering 2015-05-21 to 2015-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004) [Phase 2]